Baxter launches $2B share repurchase program; Brazil's medical device regulators are on strike;

 @FierceMedDev: Now that SCOTUS has upheld the national health reform law, winners and losers are lining up. Slideshow | Follow @FierceMedDev

 @MarkHFierce: NEA closes its massive VC fund--the 14th--with $2.6 billion in committed capital. Release | Follow @MarkHFierce

 @DamianFierce: Thermo Fisher posts 9% Q2 revenue growth on strong diagnostics sales. Story | Follow @DamianFierce

> Exact Sciences said it lost $14.8 million during its fiscal 2012 second-quarter, compared to a $6.6 million net loss over the same period in 2011, as it advances clinical trial work on its Cologuard non-invasive colorectal cancer screening test. Release

> Medical device and other life sciences industry groups can once again take Massachusetts doctors out for "modest meals and refreshments" now that legislators have repealed a highly-contested gift ban law. Story

> Baxter International ($BAX) has embarked on a program to repurchase up to $2 billion of its common stock. Release

> Illumina's ($ILMN) second-quarter profits fell 24%, while the company's revenues dipped by 2%. More

> Guided Therapeutics and the FDA have hashed out a plan to amend its PMA submission for its LuViva advanced cervical scan, a non-invasive device designed to instantly detect cervical disease that can lead to cancer. Release

> Cook Medical has launched Aprima, a nonvascular introducer set for interventional radiology. News

> Anaxys has filed a 510(k) application with the FDA for its respiR8 continuous respiratory rate counter, which monitors respiratory rates after surgery. The product already has a CE mark. Release

Biotech News

 @FierceBiotech: Sanofi sets out to reinvent itself in Genzyme's biotech image. More | Follow @FierceBiotech

 @JohnCFierce: Busy biotech investor NEA unveils $2.6B global fund--says venture money controlled by a smaller number of global players. Story | Follow @JohnCFierce

 @RyanMFierce: China market may grow faster than U.S. for trials tech eClinical, but I don't see that hurting U.S. software cos. Article | Follow @RyanMFierce

> ThromboGenics jolted with safety questions on eve of FDA panel review. News

> Busy biotech investor NEA unveils $2.6B global fund. Report

> Rusnano, Domain team top up CoDa venture round with $20M. Article

> Bluebird adds $60M venture haul to finance pivotal gene therapy study. Story

Pharma News

 @FiercePharma: U.K.'s rolling out flu vax program for all kids, using AstraZeneca's spray immunization. Report | Follow @FiercePharma

> Glaxo sales slump in Europe, US on price cuts, generics. News

> Lilly sales reel from Zyprexa loss, but Cymbalta offers aid. Article

> Generics take a billion-dollar bite from Bristol-Myers sales. More

> FDA spanks Sanofi vaccine plant for violations. Item

Drug Delivery News

> Chiasma closes multimillion funding to support oral acromegaly trial. Story

> Gels and rings--using drug delivery to protect against HIV. Article

> Taking insulin could be as simple as moisturizing. News

> Microneedles deliver drugs where eyedrops can't. More

Biomarkers News

> Genetic markers pinpoint medulloblastoma as four diseases, not one. News

> Blood test could predict risk of death from hypertension. Story

> Could markers manage milk allergy? More

> Sodium in the brain marks disability in MS. Article

And Finally... Employees of Brazil's medical device regulatory arm ANVISA are on strike, leading to delays for companies seeking regulatory approval to sell their products in the country. Story

Suggested Articles

The drug that treats atrial fibrillation, flecainide, has been around since the '80s. Grace Colón, CEO of InCarda, thinks it needs a face-lift.

3M, maker of the ubiquitous Littmann stethoscope brand, has teamed up with Eko to create a new digital version that amplifies sounds and adds AI.

Study data from Medtronic showed more patients reported improvements in their chronic back pain after treatments with the devicemaker’s tiny implant.